Bahl & Gaynor Inc Mesa Laboratories Inc Transaction History

Bahl & Gaynor Inc

$19.3 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$90.62 - $114.1 $181 - $228	-2 Reduced 0.02%	8,986 $986,000
Q4 2023 Feb 02, 2024	SELL	$84.55 - $115.06 $3,973 - $5,407	-47 Reduced 0.52%	8,988 $941,000
Q3 2023 Nov 03, 2023	BUY	$104.28 - $143.36 $406,900 - $559,390	3,902 Added 76.02%	9,035 $949,000
Q2 2023 Aug 14, 2023	SELL	$125.33 - $184.35 $1,127 - $1,659	-9 Reduced 0.18%	5,133 $659,000
Q1 2023 May 03, 2023	BUY	$163.15 - $203.76 $46,987 - $58,682	288 Added 5.93%	5,142 $898,000
Q4 2022 Feb 10, 2023	BUY	$118.55 - $188.84 $575,441 - $916,629	4,854 New	4,854 $806,000
Q1 2022 May 12, 2022	SELL	$248.18 - $329.02 $1.39 Million - $1.84 Million	-5,588 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$295.95 - $332.41 $12,725 - $14,293	-43 Reduced 0.76%	5,588 $1.83 Million
Q3 2021 Nov 15, 2021	SELL	$266.92 - $322.44 $813,038 - $982,152	-3,046 Reduced 35.1%	5,631 $1.7 Million
Q2 2021 Aug 06, 2021	SELL	$235.0 - $272.85 $779,965 - $905,589	-3,319 Reduced 27.67%	8,677 $2.35 Million
Q1 2021 May 11, 2021	SELL	$243.02 - $297.01 $296,727 - $362,649	-1,221 Reduced 9.24%	11,996 $2.92 Million
Q4 2020 Feb 02, 2021	BUY	$258.4 - $289.99 $48,837 - $54,808	189 Added 1.45%	13,217 $3.79 Million
Q3 2020 Nov 12, 2020	SELL	$211.1 - $255.87 $81,484 - $98,765	-386 Reduced 2.88%	13,028 $3.32 Million
Q2 2020 Aug 13, 2020	SELL	$208.55 - $264.25 $68,404 - $86,674	-328 Reduced 2.39%	13,414 $2.91 Million
Q1 2020 May 26, 2020	BUY	$190.69 - $270.25 $2.62 Million - $3.71 Million	13,742 New	13,742 $3.11 Million
Q1 2020 May 15, 2020	SELL	$190.69 - $270.25 $2.58 Million - $3.66 Million	-13,525 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$213.21 - $251.5 $12,792 - $15,090	60 Added 0.45%	13,525 $3.37 Million
Q3 2019 Nov 14, 2019	BUY	$206.69 - $258.29 $4,340 - $5,424	21 Added 0.16%	13,465 $3.2 Million
Q2 2019 Aug 12, 2019	BUY	$185.45 - $260.0 $55,264 - $77,480	298 Added 2.27%	13,444 $3.28 Million
Q1 2019 May 13, 2019	BUY	$204.75 - $240.24 $64,086 - $75,195	313 Added 2.44%	13,146 $3.03 Million
Q4 2018 Feb 12, 2019	SELL	$171.0 - $221.34 $162,963 - $210,937	-953 Reduced 6.91%	12,833 $2.67 Million
Q3 2018 Nov 09, 2018	BUY	$181.0 - $222.93 $58,463 - $72,006	323 Added 2.4%	13,786 $2.56 Million
Q2 2018 Aug 14, 2018	SELL	$142.4 - $211.08 $1.88 Million - $2.78 Million	-13,172 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$124.77 - $152.86 $90,707 - $111,129	727 Added 5.84%	13,172 $1.96 Million
Q4 2017 Feb 13, 2018	SELL	$124.3 - $160.83 $12,430 - $16,083	-100 Reduced 0.8%	12,445 $1.55 Million
Q3 2017 Nov 13, 2017	BUY	$128.64 - $149.96 $239,913 - $279,675	1,865 Added 17.46%	12,545 $1.87 Million
Q2 2017 Aug 11, 2017	BUY	N/A	1,895 Added 21.57%	10,680 $1.53 Million
Q2 2017 Aug 10, 2017	BUY	N/A	8,785	8,785 $1.08 Million

Others Institutions Holding MLAB

# of Institutions

173

Shares Held

4.99M

Call Options Held

Put Options Held

View Full List

About MESA LABORATORIES INC

Ticker MLAB
Exchange NASDAQ
Sector Technology
Industry Scientific & Technical Instruments
Shares Outstandng 5,317,270
Market Cap $691M
Description
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the ...

More about MLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account